JPWO2018201192A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2018201192A5
JPWO2018201192A5 JP2019560254A JP2019560254A JPWO2018201192A5 JP WO2018201192 A5 JPWO2018201192 A5 JP WO2018201192A5 JP 2019560254 A JP2019560254 A JP 2019560254A JP 2019560254 A JP2019560254 A JP 2019560254A JP WO2018201192 A5 JPWO2018201192 A5 JP WO2018201192A5
Authority
JP
Japan
Prior art keywords
carbon atoms
heteroatom
heterocyclic
heterocyclyl
term
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019560254A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020518621A (ja
JP7788128B2 (ja
JP2020518621A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2018/050404 external-priority patent/WO2018201192A1/en
Publication of JP2020518621A publication Critical patent/JP2020518621A/ja
Priority to JP2023101906A priority Critical patent/JP2023134493A/ja
Publication of JPWO2018201192A5 publication Critical patent/JPWO2018201192A5/ja
Publication of JP2020518621A5 publication Critical patent/JP2020518621A5/ja
Application granted granted Critical
Publication of JP7788128B2 publication Critical patent/JP7788128B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019560254A 2017-05-03 2018-05-03 呼吸器疾患の治療のための化合物 Active JP7788128B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023101906A JP2023134493A (ja) 2017-05-03 2023-06-21 呼吸器疾患の治療のための化合物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2017901611A AU2017901611A0 (en) 2017-05-03 Compounds for the treatment of respiratory diseases
AU2017901611 2017-05-03
AU2017901647A AU2017901647A0 (en) 2017-05-05 Compounds for the treatment of respiratory diseases
AU2017901647 2017-05-05
PCT/AU2018/050404 WO2018201192A1 (en) 2017-05-03 2018-05-03 Compounds for the treatment of respiratory diseases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023101906A Division JP2023134493A (ja) 2017-05-03 2023-06-21 呼吸器疾患の治療のための化合物

Publications (4)

Publication Number Publication Date
JP2020518621A JP2020518621A (ja) 2020-06-25
JPWO2018201192A5 true JPWO2018201192A5 (https=) 2025-04-14
JP2020518621A5 JP2020518621A5 (https=) 2025-04-14
JP7788128B2 JP7788128B2 (ja) 2025-12-18

Family

ID=64015663

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019560254A Active JP7788128B2 (ja) 2017-05-03 2018-05-03 呼吸器疾患の治療のための化合物
JP2023101906A Withdrawn JP2023134493A (ja) 2017-05-03 2023-06-21 呼吸器疾患の治療のための化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023101906A Withdrawn JP2023134493A (ja) 2017-05-03 2023-06-21 呼吸器疾患の治療のための化合物

Country Status (9)

Country Link
US (2) US20200079757A1 (https=)
EP (1) EP3619204B1 (https=)
JP (2) JP7788128B2 (https=)
CN (1) CN110753688A (https=)
AU (3) AU2018262108A1 (https=)
ES (1) ES3049333T3 (https=)
FI (1) FI3619204T3 (https=)
PT (1) PT3619204T (https=)
WO (1) WO2018201192A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107847480B (zh) 2015-03-23 2021-06-25 墨尔本大学 呼吸性疾病的治疗
JP7575099B2 (ja) * 2018-11-07 2024-10-29 ティアンリ バイオテック プロプライエタリ リミテッド 呼吸器疾患の処理のための新規な化合物
CN110452880B (zh) * 2019-09-09 2021-09-21 温州医科大学附属第一医院 急性肺损伤细胞模型的制备方法及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593992A (en) * 1993-07-16 1997-01-14 Smithkline Beecham Corporation Compounds
IL110296A (en) * 1993-07-16 1999-12-31 Smithkline Beecham Corp Imidazole compounds process for their preparation and pharmaceutical compositions containing them
US5593991A (en) * 1993-07-16 1997-01-14 Adams; Jerry L. Imidazole compounds, use and process of making
IL118544A (en) * 1995-06-07 2001-08-08 Smithkline Beecham Corp History of imidazole, the process for their preparation and the pharmaceutical preparations containing them
WO1999032121A1 (en) * 1997-12-19 1999-07-01 Smithkline Beecham Corporation Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses
SI2493876T1 (sl) * 2009-10-28 2014-04-30 Pfizer Inc. Derivati imidazola kot inhibitorji kazein-kinaze
CZ2012538A3 (cs) * 2012-08-08 2014-02-19 Masarykova Univerzita Inhibitory pro léčbu B-buněčné chronické lymfocytární leukémie
CN107847480B (zh) * 2015-03-23 2021-06-25 墨尔本大学 呼吸性疾病的治疗

Similar Documents

Publication Publication Date Title
EA201001595A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
UY29421A1 (es) Nuevos compuestos de n-(n-sulfonilaminoarilmetil) ciclopropanocarboxanida sustituidos, comoposiciones farmacéuticas que los contienen a aplicaciones.
AR040351A1 (es) Derivados de quinuclidina-amida, composicion farmaceutica, procedimiento de preparacion del compuesto y su uso para fabricar medicamentos
UY29389A1 (es) Derivados sustituidos del ácido1-((4-((((3,3-dimetil-2-oxo-2,3-dihidro-1h-indol-1-il)carbonil)amino)metil)piperidin-1-il)metil)ciclobutanocarboxílico, sales farmaceuticamente aceptables, composiciones que los contienen y aplicaciones.
JP7233059B2 (ja) 結核に対する薬剤と組み合わせた環融合型チアゾリノ２－ピリドン
UA74160C2 (uk) Похідні фенілпіперазину
ECSP067079A (es) Derivados de ácido carboxílico de bencimidazolona
EA200601194A1 (ru) Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором
BR112022003704A2 (pt) Compostos de 4,4a,5,7,8,8a-hexapirido[4,3-b][1,4]oxazin-3-ona como inibidores de magl
JPWO2018201192A5 (https=)
US20210251942A1 (en) 2-naphthimidamides, analogues thereof, and methods of treatment using same
PE20040606A1 (es) 4-amino-1-(piridilmetil)piperidina sustituida y compuestos relacionados
DK239788D0 (da) Beta-d-phenyl-thioxylosider, fremgangsmaade til deres fremstilling og deres anvendelse som terapeutika
BRPI0509390A (pt) derivados de 1-(1h-indol-1-il)-3-(4-metilpiperazin-1-il)-fenil propan-2-ol e compostos relacionados como moduladores da atividade da norepinefrina (ne) e da serotonina (5-th) e da reabsorção da monoamina para o tratamento de sintomas vasomotores (vms)
TW200901999A (en) Amide derivatives
DE602006010563D1 (de) Indazolcarbonsäureamidderivate als agonisten des 5ht4-rezeptors
Sabbah et al. A new route towards fimbrolide analogues: importance of the exomethylene motif in LuxR dependent quorum sensing inhibition
CO2025007987A2 (es) Derivados de tiadiazol como inhibidores de la sintasa de gmp-amp cíclico y usos de los mismos
EA200700807A1 (ru) Новые циклические и ациклические пропеноны для лечения заболеваний цнс
JP5621037B2 (ja) アルキルジアミン類誘導体及びその抗うつ薬としての使用
EA200702626A1 (ru) Новые замещённые тетрациклические производные тетрагидрофурана, пирролидина и тетрагидротиофена и их применение в качестве лекарственного средства
TR200909787A2 (tr) Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
JP1819699S (ja) 楽器用保護袋
SU471106A1 (ru) Способ очистки технологического газа от высококип щих примесей
BRPI0417828A (pt) cicloexadepsipeptìdeos de 18 membros, substituìdos com nitrobenzila e aminobenzila, para controle de endoparasitas e processo para preparação dos mesmos